8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of report (Date of earliest event reported):  October 22, 2009

(Exact name of registrant as specified in its charter)

New Jersey	I-3215	22-1024240
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

One Johnson & Johnson Plaza, New Brunswick, New Jersey  08933

(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code:  732-524-0400

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o           Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o           Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o           Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o           Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02.  Departure of Directors of Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements for Certain Officers.

On October 22, 2009, Anne M. Mulcahy, Chairman of Xerox Corporation, was appointed to the Board of Directors of Johnson & Johnson.  The Company’s press release announcing the appointment is attached to this Report as Exhibit 99.1.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Johnson & Johnson
		(Registrant)
Date:  October 22, 2009	By:	/S/  STEVEN M. ROSENBERG
		Steven M. Rosenberg
		Secretary

EX-99.1

EXHIBIT 99.1

Press Contact:                      Jeff Leebaw

732-524-3350

For Immediate Release

Xerox Chairman Anne M. Mulcahy

Appointed to Johnson & Johnson Board of Directors

New Brunswick, NJ (October 22, 2009) – Anne M. Mulcahy, Chairman of Xerox Corporation (NYSE:XRX), today was appointed to the Board of Directors of Johnson & Johnson (NYSE:JNJ), the world’s most broadly based health care products company.

Mulcahy was both chairman and chief executive officer of Xerox until July when she retired as CEO after eight years in the position. Prior to serving as CEO, Mulcahy was president and chief operating officer of Xerox. She has also served as president of Xerox’s General Markets Operations, which created and sold products for reseller, dealer and retail channels.

“Anne is one of our nation’s most accomplished business leaders,” said William C. Weldon, chairman and chief executive officer of Johnson & Johnson. “She adds an extraordinary breadth of business expertise and experience to our board. We look forward to her insights and counsel, and are delighted to welcome her to the board.”

 During a career at Xerox that began in 1976, Mulcahy has also served as vice president for human resources with responsibility for compensation, benefits, human resource strategy, labor relations, management development and employee training; and vice president and staff officer for Customer Operations, covering South America and Central America, Europe, Asia and Africa, and China.

She is a board director of the Target Corporation, Citigroup, Inc., and The Washington Post. Mulcahy earned a bachelor of arts degree in English/journalism from Marymount College in Tarrytown, N.Y.

###